Reston Wealth Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Reston Wealth Management's LLY Position: Q1 2026 in Review
Reston Wealth Management reduced its Eli Lilly (LLY) stake by 1.6% in Q1 2026, selling an estimated $14.2K and leaving 884 shares worth $813K. The position accounts for 0.25% of the portfolio, ranked #26.
Reston Wealth Management first reported a position in LLY in Q2 2021 and has held it in 20 quarters since. The position peaked at $965K in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Reston Wealth Management held 884 shares of Eli Lilly worth $813K as of Q1 2026.
- Reston Wealth Management sold 14 Eli Lilly shares in Q1 2026, an estimated $14.2K.
- Eli Lilly made up 0.25% of Reston Wealth Management's portfolio in Q1 2026, its #26 holding.
- Reston Wealth Management first reported a position in Eli Lilly in Q2 2021 and has held it in 20 quarters since.
- Reston Wealth Management's Eli Lilly position peaked at $965K in Q4 2025.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Reston Wealth Management's 13F filing for Q1 2026, filed 13 Apr 2026.